{"id":3846,"date":"2022-05-03T08:06:21","date_gmt":"2022-05-03T07:06:21","guid":{"rendered":"https:\/\/ceptonstrategies.com\/en\/?p=3846"},"modified":"2022-05-03T14:38:21","modified_gmt":"2022-05-03T13:38:21","slug":"vintura-and-cepton-join-forces","status":"publish","type":"post","link":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/","title":{"rendered":"Vintura and Cepton join forces!"},"content":{"rendered":"

The new company will provide a holistic value proposition to clients in the life science industry and healthcare, across major European markets.<\/em><\/p>\n

 <\/p>\n

Amsterdam and Paris, May 3 2022<\/strong>: Cepton and Vintura are pleased to announce their merger, effective May 1st, 2022. The merger complements and enhances existing services offered by the two companies. Together, the two companies provide clients with extensive subject matter expertise and strategy consulting in key areas. With offices in the main European markets, such as Germany, UK, Benelux and France, the combined companies primarily deliver their services in Europe, while also serving global clients. This move is a pivotal first step to deliver unparalleled solutions to the fast-growing joint client base.<\/p>\n

The merger between Vintura and Cepton will provide mutual benefits for both organizations and a stronger value proposition for the clients. Beyond traditional strategy and organization consulting skills, which both companies share, Cepton will bring expertise in transaction services for Private Equity, while Vintura will bring deep knowledge of services for Healthcare providers. Additionally, Vintura has a strong track record with big pharma, while Cepton has long-standing relationships with mid-size pharma, biotech, Private Equity and Venture Capital. For now, both companies will continue to operate under their well-established brands.<\/p>\n

\u201cThe merger with Cepton is a key step in our transformation journey to become THE<\/em> International Life Science & Healthcare Strategy Boutique<\/em>\u201d, explains G\u00e9rard Klop, Founding Partner at Vintura.\u00a0\u201cWe want to serve our customers better and with more impact. To have maximum impact we believe, you need to share your client\u2019s language and culture, be near and have knowledge of and experience within the local healthcare system. The merger with Cepton, who are headquartered in France, will allow us to service current and new clients in one of the top five European markets\u201d <\/em>he adds.<\/p>\n

Jean Reboullet, Founding Partner at Cepton states: \u201cThe merger will further solidify our presence in Europe, provide new opportunities and access to other healthcare markets and clients, as well as augment our portfolio with additional expertise and services.\u201d<\/em><\/p>\n

G\u00e9rard details: \u201dBoth companies strongly believe in the power of diversified teams, especially in consulting, where offering new perspectives is key.\u201d<\/em> Jean adds: \u201dAnd most of all, Cepton and Vintura share the same values.\u201d.<\/em><\/p>\n

Vintura is a leading strategy consultancy company specialized in life sciences and healthcare across Europe. The company provides strategic and organizational consultancy services in the pharmaceutical and medical device sector, as well as in healthcare for care providers and payers. Vintura consists of 55+ dedicated professionals and has offices in the Netherlands, UK and Germany and is currently further expanding into Europe.\u00a0 Vintura is part of the international PharmaLex Group, a leading worldwide provider of holistic solutions for the pharma, biotech and medtech industry.<\/p>\n

Cepton is a healthcare strategy consultancy boutique headquartered in Paris, with 35 + professionals. They have similar and complementary services compared to Vintura and share the same ambition, values and professional standards. They have been voted top-3 healthcare strategy consultants in France for four years in a row.
\n<\/em><\/p>\n

<\/p>","protected":false},"excerpt":{"rendered":"

The new company will provide a holistic value proposition to clients in the life science industry and healthcare, across major European markets.   Amsterdam and Paris, May 3 2022: Cepton and Vintura are pleased to announce their merger, effective May 1st, 2022. The merger complements and enhances existing services offered by the two companies. Together, […]<\/p>\n","protected":false},"author":4,"featured_media":3843,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[99,11],"tags":[],"yoast_head":"\nVintura and Cepton join forces! – Consulting Firm in Pharmaceutical, MedTech & Healthcare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vintura and Cepton join forces! – Consulting Firm in Pharmaceutical, MedTech & Healthcare\" \/>\n<meta property=\"og:description\" content=\"The new company will provide a holistic value proposition to clients in the life science industry and healthcare, across major European markets.   Amsterdam and Paris, May 3 2022: Cepton and Vintura are pleased to announce their merger, effective May 1st, 2022. The merger complements and enhances existing services offered by the two companies. Together, […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/\" \/>\n<meta property=\"og:site_name\" content=\"Consulting Firm in Pharmaceutical, MedTech & Healthcare\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-03T07:06:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-03T13:38:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2022\/05\/Cepton-Vintura-square.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"367\" \/>\n\t<meta property=\"og:image:height\" content=\"294\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marc-Olivier B\u00e9vierre\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marc-Olivier B\u00e9vierre\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/\"},\"author\":{\"name\":\"Marc-Olivier B\u00e9vierre\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3\"},\"headline\":\"Vintura and Cepton join forces!\",\"datePublished\":\"2022-05-03T07:06:21+00:00\",\"dateModified\":\"2022-05-03T13:38:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/\"},\"wordCount\":507,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2022\/05\/Cepton-Vintura-square.jpg\",\"articleSection\":[\"2022\",\"In the press\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/\",\"url\":\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/\",\"name\":\"Vintura and Cepton join forces! – Consulting Firm in Pharmaceutical, MedTech & Healthcare\",\"isPartOf\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2022\/05\/Cepton-Vintura-square.jpg\",\"datePublished\":\"2022-05-03T07:06:21+00:00\",\"dateModified\":\"2022-05-03T13:38:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#primaryimage\",\"url\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2022\/05\/Cepton-Vintura-square.jpg\",\"contentUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2022\/05\/Cepton-Vintura-square.jpg\",\"width\":367,\"height\":294},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ceptonstrategies.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vintura and Cepton join forces!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ceptonstrategies.com\/#website\",\"url\":\"https:\/\/ceptonstrategies.com\/\",\"name\":\"Cepton Stategies Conseil\",\"description\":\"CEPTON is a parisian consulting firm. Our senior consultants are specialized in the pharmaceutical, medtech and healthcare industries\",\"publisher\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ceptonstrategies.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ceptonstrategies.com\/#organization\",\"name\":\"Cepton Strategies\",\"url\":\"https:\/\/ceptonstrategies.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg\",\"contentUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg\",\"width\":938,\"height\":423,\"caption\":\"Cepton Strategies\"},\"image\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/strategies-cepton\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3\",\"name\":\"Marc-Olivier B\u00e9vierre\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g\",\"caption\":\"Marc-Olivier B\u00e9vierre\"},\"url\":\"https:\/\/ceptonstrategies.com\/en\/author\/marc-olivier\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vintura and Cepton join forces! – Consulting Firm in Pharmaceutical, MedTech & Healthcare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/","og_locale":"en_US","og_type":"article","og_title":"Vintura and Cepton join forces! – Consulting Firm in Pharmaceutical, MedTech & Healthcare","og_description":"The new company will provide a holistic value proposition to clients in the life science industry and healthcare, across major European markets.   Amsterdam and Paris, May 3 2022: Cepton and Vintura are pleased to announce their merger, effective May 1st, 2022. The merger complements and enhances existing services offered by the two companies. Together, […]","og_url":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/","og_site_name":"Consulting Firm in Pharmaceutical, MedTech & Healthcare","article_published_time":"2022-05-03T07:06:21+00:00","article_modified_time":"2022-05-03T13:38:21+00:00","og_image":[{"width":367,"height":294,"url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2022\/05\/Cepton-Vintura-square.jpg","type":"image\/jpeg"}],"author":"Marc-Olivier B\u00e9vierre","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marc-Olivier B\u00e9vierre","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#article","isPartOf":{"@id":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/"},"author":{"name":"Marc-Olivier B\u00e9vierre","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3"},"headline":"Vintura and Cepton join forces!","datePublished":"2022-05-03T07:06:21+00:00","dateModified":"2022-05-03T13:38:21+00:00","mainEntityOfPage":{"@id":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/"},"wordCount":507,"commentCount":0,"publisher":{"@id":"https:\/\/ceptonstrategies.com\/#organization"},"image":{"@id":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#primaryimage"},"thumbnailUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2022\/05\/Cepton-Vintura-square.jpg","articleSection":["2022","In the press"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/","url":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/","name":"Vintura and Cepton join forces! – Consulting Firm in Pharmaceutical, MedTech & Healthcare","isPartOf":{"@id":"https:\/\/ceptonstrategies.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#primaryimage"},"image":{"@id":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#primaryimage"},"thumbnailUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2022\/05\/Cepton-Vintura-square.jpg","datePublished":"2022-05-03T07:06:21+00:00","dateModified":"2022-05-03T13:38:21+00:00","breadcrumb":{"@id":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#primaryimage","url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2022\/05\/Cepton-Vintura-square.jpg","contentUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2022\/05\/Cepton-Vintura-square.jpg","width":367,"height":294},{"@type":"BreadcrumbList","@id":"https:\/\/ceptonstrategies.com\/en\/vintura-and-cepton-join-forces\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ceptonstrategies.com\/en\/"},{"@type":"ListItem","position":2,"name":"Vintura and Cepton join forces!"}]},{"@type":"WebSite","@id":"https:\/\/ceptonstrategies.com\/#website","url":"https:\/\/ceptonstrategies.com\/","name":"Cepton Stategies Conseil","description":"CEPTON is a parisian consulting firm. Our senior consultants are specialized in the pharmaceutical, medtech and healthcare industries","publisher":{"@id":"https:\/\/ceptonstrategies.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ceptonstrategies.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ceptonstrategies.com\/#organization","name":"Cepton Strategies","url":"https:\/\/ceptonstrategies.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/","url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg","contentUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg","width":938,"height":423,"caption":"Cepton Strategies"},"image":{"@id":"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/strategies-cepton"]},{"@type":"Person","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3","name":"Marc-Olivier B\u00e9vierre","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g","caption":"Marc-Olivier B\u00e9vierre"},"url":"https:\/\/ceptonstrategies.com\/en\/author\/marc-olivier\/"}]}},"_links":{"self":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts\/3846"}],"collection":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/comments?post=3846"}],"version-history":[{"count":5,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts\/3846\/revisions"}],"predecessor-version":[{"id":3857,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts\/3846\/revisions\/3857"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/media\/3843"}],"wp:attachment":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/media?parent=3846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/categories?post=3846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/tags?post=3846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}